When will Oxaliplatin Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Oxaliplatin Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Oxaliplatin Injection

Brand names: Oxaliplatin

Category: Oncology

Not specified 6

FDA status: To Be Discontinued · Last FDA update: Oct 20, 2025 · First posted: Feb 25, 2026 · 3 manufacturers, 6 listed presentations

As of Oct 20, 2025, the FDA lists Oxaliplatin Injection as being discontinued. Of 6 manufacturer presentations, 6 Not specified.

Ask your pharmacist: which of the 3 manufacturers below can they order right now, and whether a different strength or form of Oxaliplatin Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10) NDC 25021-233-10	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	Not specified	Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) NDC 25021-233-20	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	Not specified	Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70) NDC 0781-3315-70	Sandoz Inc.	Not specified	Discontinuation of the manufacture of the drug
Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80) NDC 0781-3317-80	Sandoz Inc.	Not specified	Discontinuation of the manufacture of the drug
Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10) NDC 63323-750-10	Fresenius Kabi USA, LLC	Not specified	A business decision was made to discontinue manufacture of the drug.
Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20) NDC 63323-750-20	Fresenius Kabi USA, LLC	Not specified	A business decision was made to discontinue manufacture of the drug.

Related medications in shortage

Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Oxaliplatin Injection (FDA data as of Oct 20, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Oxaliplatin Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Oxaliplatin Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/oxaliplatin-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).